Basic Information
RNALocate ID: | RLID:01002790 |
RNA Symbol: | hsa-miR-1275 |
Localization: | Nucleolus |
RNA Information
RNA Name: | hsa-miR-1275 |
RNA ID: | miRBase:MIMAT0005929 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23940654 |
Tissue/Cell Line: | HeLa cells |
Method: | qRT-PCR |
Detection of mature miRNAs in the HeLa nucleolus. The abundance ratios of the detected miRNAs in nucleolus vs. whole cells are plotted against their abundance in the nucleolus. The box encompasses the miRNAs with high nucleolar abundance (Ct smaller than 30) and nucleolar/cell ratio that exceeds 0.3. Originally published in PLoS One. Li ZF, et al, 2013. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) |
|
Description: | Even under such stringent criteria, 11 miRNAs can be identified as miRNAs that are detectable in the nucleolus with very high levels of confidence (Figure 1D, Table S2). Since the detected nucleolar contents of many of these RNAs are very high, we termed these 11 miRNAs as “nucleolar miRNAs”. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002786 | Mitochondrion | HeLa cells | 27396686 |
RLID:01002787 | Mitochondrion | HeLa cells | 27563705 |
RLID:01002788 | Mitochondrion | Cell line (HeLa) | 21695135 |
RLID:01002789 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01002837 | Cytosol | Cell line (HeLa) | 21695135 |
RLID:01002838 | Mitochondrion | Cell line (HeLa) | 21695135 |
RLID:11004346 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11004347 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
RLID:11004348 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11000791 | Microvesicle | Colon cancer cell line (LIM1863)|Mesenchymal stem cells | |
RLID-D:11001721 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-1275 | Oral squamous cell carcinoma | MNDR-E-MI-08791 |
MNDR | hsa-miR-1275 | Estrogen-receptor positive breast cancer | MNDR-E-MI-08792 |
MNDR | hsa-miR-1275 | Estrogen-receptor negative breast cancer | MNDR-E-MI-08793 |
MNDR | hsa-miR-1275 | Progesterone-receptor positive breast cancer | MNDR-E-MI-08794 |
MNDR | hsa-miR-1275 | Progesterone-receptor negative breast cancer | MNDR-E-MI-08795 |
MNDR | hsa-miR-1275 | Her2-receptor positive breast cancer | MNDR-E-MI-08796 |
MNDR | hsa-miR-1275 | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-08797 |
MNDR | hsa-mir-1275 | Colorectal carcinoma | MNDR-E-MI-08798 |
MNDR | hsa-miR-1275 | B cell acute lymphoblastic leukemia | MNDR-E-MI-08799 |
MNDR | hsa-miR-1275 | Prostate cancer | MNDR-E-MI-08800 |
MNDR | hsa-miR-1275 | Alzheimer disease | MNDR-E-MI-08801 |
MNDR | hsa-miR-1275 | Intracranial aneurysm | MNDR-E-MI-08802 |
MNDR | hsa-miR-1275 | Polycystic ovary syndrome | MNDR-E-MI-08803 |
MNDR | hsa-miR-1275 | Head and neck cancer | MNDR-E-MI-08804 |
MNDR | hsa-miR-1275 | Lung cancer | MNDR-E-MI-08805 |
MNDR | hsa-miR-1275 | Parkinson disease | MNDR-E-MI-08806 |
MNDR | hsa-miR-1275 | Breast cancer | MNDR-E-MI-08807 |
MNDR | hsa-mir-1275 | Squamous carcinoma | MNDR-E-MI-08808 |
MNDR | hsa-miR-1275 | Pancreatic cancer | MNDR-E-MI-08809 |
MNDR | hsa-miR-1275 | Nephroblastoma | MNDR-E-MI-08810 |
MNDR | hsa-miR-1275 | Multiple sclerosis | MNDR-E-MI-08811 |
MNDR | hsa-miR-1275 | Multiple sclerosis relapsing-remitting | MNDR-E-MI-08812 |
MNDR | hsa-miR-1275 | Ovarian cancer | MNDR-E-MI-08813 |
MNDR | hsa-miR-1275 | Glioma | MNDR-E-MI-08814 |
MNDR | hsa-miR-1275 | Amyotrophic lateral sclerosis | MNDR-E-MI-08815 |
MNDR | hsa-miR-1275 | Liver cancer | MNDR-E-MI-08816 |
MNDR | hsa-mir-1275 | Non-small cell lung cancer | MNDR-E-MI-08817 |
MNDR | hsa-miR-1275 | Lung adenocarcinoma | MNDR-E-MI-08818 |
MNDR | hsa-miR-1275 | Thyroid carcinoma | MNDR-E-MI-08819 |
MNDR | hsa-miR-1275 | Pancreatic adenocarcinoma | MNDR-E-MI-08820 |
MNDR | hsa-miR-1275 | Intrahepatic cholangiocarcinoma | MNDR-E-MI-08821 |
MNDR | hsa-miR-1275 | Cholangiocarcinoma | MNDR-E-MI-08822 |
MNDR | hsa-miR-1275 | Adenoma | MNDR-E-MI-08823 |
MNDR | hsa-miR-1275 | Progressive supranuclear palsy | MNDR-E-MI-08824 |
MNDR | hsa-mir-1275 | Carcinoma hepatocellular | MNDR-E-MI-08825 |
MNDR | hsa-miR-1275 | Hepatocellular carcinoma | MNDR-E-MI-08826 |
MNDR | hsa-miR-1275 | Hodgkin lymphoma | MNDR-E-MI-08827 |
MNDR | hsa-miR-1275 | Acute myelocytic leukemia | MNDR-E-MI-08828 |
MNDR | hsa-mir-1275 | Colorectal cancer | MNDR-E-MI-08829 |
MNDR | hsa-mir-1275 | Nasopharyngeal carcinoma | MNDR-E-MI-08830 |
MNDR | hsa-miR-1275 | Nasopharynx carcinoma | MNDR-E-MI-08831 |
MNDR | hsa-miR-1275 | Nasopharyngeal cancer | MNDR-E-MI-08832 |
MNDR | hsa-miR-1275 | Pseudorabies | MNDR-E-MI-08833 |
MNDR | hsa-miR-1275 | Subarachnoid hemorrhage traumatic | MNDR-E-MI-08834 |
MNDR | hsa-miR-1275 | Stroke lacunar | MNDR-E-MI-08835 |
MNDR | hsa-miR-1275 | Breast cancer her3+ negative | MNDR-E-MI-08836 |
MNDR | hsa-mir-1275 | Multiple sclerosis susceptibility | MNDR-E-MI-08837 |
MNDR | hsa-mir-1275 | Stroke susceptibility | MNDR-E-MI-08838 |
MNDR | hsa-miR-1275 | Tubulovillous adenoma | MNDR-E-MI-08839 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | AK3 | Homo sapiens | RR00064570 |
TOP